BIOGEN INC
BIIBNASDAQ$226.65▼ $2.02 (−0.89%)
LiveTrack BIIB
Get earnings, price moves & breaking news on Telegram
24h▼ 0.9%
7d▲ 0.5%
14d▲ 4.9%
30d▲ 3.7%
ytd▲ 28.9%
1y▲ 63.6%
🏦Market Cap
$33.49B
Mid Cap
📈Revenue Growth (YoY)
+1.4%
Slowing
📊Gross Margin
67.7%
High
💵FCF Margin
29.8%
Strong
⚖️P/S Ratio
3.4x
Fair
Otter Score
88
Very Good
BIOGEN INC
BIIBAnalyst Ratings
Price
$226.65
Total
49
Raised
8
Lowered
7
Avg PT
$245.88
H / L
$300 / $175
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HSBC | Reiterated | Reduce | 2026-09-10 | $175.00 | −22.80% |
Piper Sandler | Reiterated | Overweight | 2026-09-03 | $245.00 | +8.10% |
RBC Capital | Reiterated | Outperform | 2026-08-25 | $260.00 | +14.70% |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2026-08-13 | $300.00 | +32.40% |
Mizuho | Reiterated | Outperform | 2026-08-04 | — | — |
Citigroup | Reiterated | Neutral | 2026-08-03 | $160.00 | −29.40% |
UBS | Reiterated | Buy | 2026-07-30 | $240.00 | +5.90% |
Wedbush | Reiterated | Neutral | 2026-07-30 | $201.00 | −11.30% |
TD Cowen | Reiterated | Buy | 2026-07-30 | — | — |
Canaccord Genuity | Reiterated | Buy | 2026-07-30 | $248.00 | +9.40% |
Morgan Stanley | Reiterated | Equal Weight | 2026-07-30 | $231.00 | +1.90% |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-30 | — | — |
Barclays | Reiterated | Equal Weight | 2026-07-29 | $185.00 | −18.40% |
Guggenheim | Reiterated | Buy | 2026-07-21 | $280.00 | +23.50% |
B of A Securities | Reiterated | Neutral | 2026-07-21 | — | — |
Truist Securities | Upgraded | Hold → Buy | 2026-07-13 | — | — |
Needham | Reiterated | Buy | 2026-06-29 | $255.00 | +12.50% |
Wells Fargo | Upgraded | Equal Weight → Overweight | 2026-04-20 | $250.00 | +10.30% |
Oppenheimer | Reiterated | Outperform | 2026-04-01 | $300.00 | +32.40% |
Freedom Broker | Reiterated | Hold | 2026-02-23 | — | — |
JP Morgan | Reiterated | Neutral | 2026-02-09 | $275.00 | +21.30% |
BMO Capital | Reiterated | Market Perform | 2026-02-09 | $196.00 | −13.50% |
Stifel | Upgraded | Hold → Buy | 2025-11-06 | — | — |
Bernstein | Reiterated | Market Perform | 2025-11-03 | $191.00 | −15.70% |
Baird | Reiterated | Outperform | 2025-05-02 | — | — |
Goldman Sachs | Reiterated | Buy | 2025-04-23 | $225.00 | −0.70% |
Argus Research | Downgraded | Buy → Hold | 2025-04-04 | — | — |
Scotiabank | Reiterated | Sector Outperform | 2025-02-13 | $275.00 | +21.30% |
Jefferies | Downgraded | Buy → Hold | 2024-12-09 | $190.00 | −16.20% |
Cantor Fitzgerald | Reiterated | Overweight | 2024-09-09 | — | — |
Raymond James | Upgraded | Market Perform → Outperform | 2023-12-07 | $315.00 | +39.00% |
Atlantic Equities | Reiterated | Neutral | 2023-08-08 | $295.00 | +30.20% |
Cowen & Co. | Reiterated | Outperform | 2023-02-16 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-10-26 | — | — |
William Blair | Upgraded | Market Perform → Outperform | 2021-06-08 | — | — |
Credit Suisse | Reiterated | Outperform | 2021-02-04 | — | — |
DZ Bank | Upgraded | Hold → Buy | 2020-11-10 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-04-23 | — | — |
Nomura | Reiterated | Buy | 2020-02-07 | — | — |
Standpoint Research | Downgraded | Buy → Hold | 2019-11-01 | — | — |
Piper Jaffray | Downgraded | Overweight → Neutral | 2019-06-28 | — | — |
Stifel Nicolaus | Downgraded | Buy → Hold | 2019-02-21 | $242.00 | +6.80% |
Argus | Downgraded | Buy → Hold | 2018-02-16 | — | — |
H.C. Wainwright | Reiterated | Buy | 2018-01-26 | $251.00 | +10.70% |
Bank of America | Reiterated | Buy | 2017-10-18 | — | — |
Leerink Swann | Downgraded | Outperform → Market Perform | 2017-03-16 | — | — |
PiperJaffray | Upgraded | Neutral → Overweight | 2016-11-07 | — | — |
Deutsche Bank | Reiterated | Buy | 2014-07-24 | — | — |
FBR Capital | Reiterated | Outperform | 2013-10-02 | — | — |
Institution
HSBC
Reiterated · Reduce · 2026-09-10
$175.00
−22.80%
Piper Sandler
Reiterated · Overweight · 2026-09-03
$245.00
+8.10%
RBC Capital
Reiterated · Outperform · 2026-08-25
$260.00
+14.70%
Wolfe Research
Upgraded · Peer Perform → Outperform · 2026-08-13
$300.00
+32.40%
Mizuho
Reiterated · Outperform · 2026-08-04
—
—
Citigroup
Reiterated · Neutral · 2026-08-03
$160.00
−29.40%
UBS
Reiterated · Buy · 2026-07-30
$240.00
+5.90%
Wedbush
Reiterated · Neutral · 2026-07-30
$201.00
−11.30%
TD Cowen
Reiterated · Buy · 2026-07-30
—
—
Canaccord Genuity
Reiterated · Buy · 2026-07-30
$248.00
+9.40%
Morgan Stanley
Reiterated · Equal Weight · 2026-07-30
$231.00
+1.90%
HC Wainwright & Co.
Reiterated · Buy · 2026-07-30
—
—
Barclays
Reiterated · Equal Weight · 2026-07-29
$185.00
−18.40%
Guggenheim
Reiterated · Buy · 2026-07-21
$280.00
+23.50%
B of A Securities
Reiterated · Neutral · 2026-07-21
—
—
Truist Securities
Upgraded · Hold → Buy · 2026-07-13
—
—
Needham
Reiterated · Buy · 2026-06-29
$255.00
+12.50%
Wells Fargo
Upgraded · Equal Weight → Overweight · 2026-04-20
$250.00
+10.30%
Oppenheimer
Reiterated · Outperform · 2026-04-01
$300.00
+32.40%
Freedom Broker
Reiterated · Hold · 2026-02-23
—
—
JP Morgan
Reiterated · Neutral · 2026-02-09
$275.00
+21.30%
BMO Capital
Reiterated · Market Perform · 2026-02-09
$196.00
−13.50%
Stifel
Upgraded · Hold → Buy · 2025-11-06
—
—
Bernstein
Reiterated · Market Perform · 2025-11-03
$191.00
−15.70%
Baird
Reiterated · Outperform · 2025-05-02
—
—
Goldman Sachs
Reiterated · Buy · 2025-04-23
$225.00
−0.70%
Argus Research
Downgraded · Buy → Hold · 2025-04-04
—
—
Scotiabank
Reiterated · Sector Outperform · 2025-02-13
$275.00
+21.30%
Jefferies
Downgraded · Buy → Hold · 2024-12-09
$190.00
−16.20%
Cantor Fitzgerald
Reiterated · Overweight · 2024-09-09
—
—
Raymond James
Upgraded · Market Perform → Outperform · 2023-12-07
$315.00
+39.00%
Atlantic Equities
Reiterated · Neutral · 2023-08-08
$295.00
+30.20%
Cowen & Co.
Reiterated · Outperform · 2023-02-16
—
—
SVB Leerink
Reiterated · Outperform · 2022-10-26
—
—
William Blair
Upgraded · Market Perform → Outperform · 2021-06-08
—
—
Credit Suisse
Reiterated · Outperform · 2021-02-04
—
—
DZ Bank
Upgraded · Hold → Buy · 2020-11-10
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-04-23
—
—
Nomura
Reiterated · Buy · 2020-02-07
—
—
Standpoint Research
Downgraded · Buy → Hold · 2019-11-01
—
—
Piper Jaffray
Downgraded · Overweight → Neutral · 2019-06-28
—
—
Stifel Nicolaus
Downgraded · Buy → Hold · 2019-02-21
$242.00
+6.80%
Argus
Downgraded · Buy → Hold · 2018-02-16
—
—
H.C. Wainwright
Reiterated · Buy · 2018-01-26
$251.00
+10.70%
Bank of America
Reiterated · Buy · 2017-10-18
—
—
Leerink Swann
Downgraded · Outperform → Market Perform · 2017-03-16
—
—
PiperJaffray
Upgraded · Neutral → Overweight · 2016-11-07
—
—
Deutsche Bank
Reiterated · Buy · 2014-07-24
—
—
FBR Capital
Reiterated · Outperform · 2013-10-02
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space